Keywords: mylan, wins, reversal, patent, dispute, over, pfizer

Mylan wins reversal in patent dispute over Pfizer's Norvasc

Article | 11 June 2007

Print This

US generic drugmaker Mylan Laboratories says that the US Court of Appeals for the Federal Circuit has reversed a prior ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in